menu
    • menu

    Company profile for RHEACELL

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RHEACELL is a biopharmaceutical leader developing breakthrough therapies for severe inflammatory diseases like RDEB and chronic venous ulcers, leveraging our proprietary ABCB5+ MSC platform (exclusively licensed from Harvard’s CMCC). Our mission: delivering transformative care for untreatable conditions. AMESANAR®, our approved cell therapy for chronic wounds (Germany, 2021), targets inflammation, enabling tissue repair and...
    RHEACELL is a biopharmaceutical leader developing breakthrough therapies for severe inflammatory diseases like RDEB and chronic venous ulcers, leveraging our proprietary ABCB5+ MSC platform (exclusively licensed from Harvard’s CMCC). Our mission: delivering transformative care for untreatable conditions. AMESANAR®, our approved cell therapy for chronic wounds (Germany, 2021), targets inflammation, enabling tissue repair and neo-vascularization. For RDEB, a devastating rare disease, EBESANAR® is in pivotal Phase 3 trials (US/EU) with a first-in-class systemic approach to reduce disease burden.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RHEACELLGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Im Neuenheimer Feld 517 69120 Heidelberg
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rheacell.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rheacell, AOP Health Partner on Cell Therapies in Europe
    Rheacell, AOP Health Partner on Cell Therapies in Europe

    27 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250527070014/en/RHEACELL-and-AOP-Health-enter-into-strategic-partnership-to-commercialize-novel-somatic-cell-therapies-in-Europe

    BUSINESSWIRE
    27 May 2025
    Share Share
    RHEACELL and AOP Health Partner for Butterfly Disease Therapies
    RHEACELL and AOP Health Partner for Butterfly Disease Therapies

    27 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250527361005/en/RHEACELL-and-AOP-Health-Strategic-Partnership-to-Deliver-Breakthrough-Therapies-for-the-Butterfly-Childrens-Disease-and-Chronic-Venous-Wounds

    BUSINESSWIRE
    27 May 2025
    Share Share
    RHEACELL: Novel Cell-Therapy Agent for Chronic Venous Ulcers
    RHEACELL: Novel Cell-Therapy Agent for Chronic Venous Ulcers

    19 Oct 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/from-chronic-to-curable-rheacell-is-developing-a-novel-cell-therapy-agent-for-the-treatment-of-chronic-venous-ulcers/?s=71

    BIOSPACE
    19 Oct 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search